Retraction notice to "Use of ivermectin in the treatment of Covid-19: A pilot trial" [Toxicol. Rep. 8 (2021) 505-510]
Toxicol Rep
.
2022 May 2:9:1023.
doi: 10.1016/j.toxrep.2022.04.009.
eCollection 2022.
Authors
Henrique Pott-Junior
1
,
Mônica Maria Bastos Paoliello
2
,
Alice de Queiroz Constantino Miguel
3
,
Anderson Ferreira da Cunha
4
,
Caio Cesar de Melo Freire
4
,
Fábio Fernandes Neves
1
,
Lucimar Retto da Silva de Avó
1
,
Meliza Goi Roscani
1
,
Sigrid De Sousa Dos Santos
1
,
Silvana Gama Florêncio Chach
1
Affiliations
1
Department of Medicine, Federal University of São Carlos (UFSCar), 13565-905 São Carlos, São Paulo, Brazil.
2
Department of Molecular Pharmacology, Albert Einstein College of Medicine, 10461 Bronx, NY, United States.
3
University Hospital of the Federal University of São Carlos (UFSCar), 13565-905 São Carlos, São Paulo, Brazil.
4
Department of Genetics and Evolution, Federal University of São Carlos (UFSCar), 13565-905 São Carlos, São Paulo, Brazil.
PMID:
35528725
PMCID:
PMC9060540
DOI:
10.1016/j.toxrep.2022.04.009
Abstract
[This retracts the article DOI: 10.1016/j.toxrep.2021.03.003.].
© 2022 The Authors.
Publication types
Retraction of Publication